{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:32:06Z","timestamp":1793604726837,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH130, ZR2017BH035"],"award-info":[{"award-number":["ZR2023MH130, ZR2017BH035"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M672073"],"award-info":[{"award-number":["2020M672073"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802397"],"award-info":[{"award-number":["81802397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03947-3","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T11:17:24Z","timestamp":1752664644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival outcomes and prognostic impact of adjuvant chemotherapy in stage IB lung adenocarcinoma with cribriform component"],"prefix":"10.1186","volume":"23","author":[{"given":"Rongyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"1","key":"3947_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"3947_CR2","doi-asserted-by":"crossref","unstructured":"Bade BC, Dela Cruz CS. Lung Cancer. 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020;41(1):1\u201324.","DOI":"10.1016\/j.ccm.2019.10.001"},{"issue":"7689","key":"3947_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"issue":"1","key":"3947_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung Cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung Cancer. J Thorac Oncol. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"3947_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/modpathol.2010.232","volume":"24","author":"A Yoshizawa","year":"2011","unstructured":"Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, et al. Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24(5):653\u201364.","journal-title":"Mod Pathol"},{"issue":"3","key":"3947_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362\u201387.","journal-title":"J Thorac Oncol"},{"key":"3947_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.lungcan.2020.07.021","volume":"147","author":"F Yang","year":"2020","unstructured":"Yang F, Dong Z, Shen Y, Shi J, Wu Y, Zhao Z, et al. Cribriform growth pattern in lung adenocarcinoma: more aggressive and poorer prognosis than acinar growth pattern. Lung Cancer. 2020;147:187\u201392.","journal-title":"Lung Cancer"},{"issue":"2","key":"3947_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jtho.2018.09.028","volume":"14","author":"K Kadota","year":"2019","unstructured":"Kadota K, Kushida Y, Kagawa S, Ishikawa R, Ibuki E, Inoue K, et al. Cribriform subtype is an independent predictor of recurrence and survival after adjustment for the eighth edition of TNM staging system in patients with resected lung adenocarcinoma. J Thorac Oncol. 2019;14(2):245\u201354.","journal-title":"J Thorac Oncol"},{"key":"3947_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.lungcan.2019.06.027","volume":"134","author":"Q Ding","year":"2019","unstructured":"Ding Q, Chen D, Wang X, Wen J, Chen C, Zhang Y, et al. Characterization of lung adenocarcinoma with a cribriform component reveals its association with spread through air spaces and poor outcomes. Lung Cancer. 2019;134:238\u201344.","journal-title":"Lung Cancer"},{"issue":"1","key":"3947_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.21037\/tlcr-20-612","volume":"10","author":"N Nakajima","year":"2021","unstructured":"Nakajima N, Yoshizawa A, Rokutan-Kurata M, Noguchi M, Teramoto Y, Sumiyoshi S, et al. Prognostic significance of cribriform adenocarcinoma of the lung: validation analysis of 1,057 Japanese patients with resected lung adenocarcinoma and a review of the literature. Transl Lung Cancer Res. 2021;10(1):117\u201327.","journal-title":"Transl Lung Cancer Res"},{"issue":"Suppl 4","key":"3947_CR11","doi-asserted-by":"publisher","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","volume":"29","author":"D Planchard","year":"2018","unstructured":"Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, et al. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv192\u2013237.","journal-title":"Ann Oncol"},{"issue":"4","key":"3947_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, et al. Non-Small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(4):249\u201374.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"3947_CR13","doi-asserted-by":"publisher","first-page":"e183242","DOI":"10.1001\/jamanetworkopen.2018.3242","volume":"1","author":"WK Yap","year":"2018","unstructured":"Yap WK, Shih MC, Kuo C, Pai PC, Chou WC, Chang KP, et al. Development and validation of a nomogram for assessing survival in patients with metastatic lung Cancer referred for radiotherapy for bone metastases. JAMA Netw Open. 2018;1(6):e183242.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3947_CR14","first-page":"317","volume":"11","author":"G Branca","year":"2017","unstructured":"Branca G, Ieni A, Barresi V, Tuccari G, Caruso RA. An updated review of cribriform carcinomas with emphasis on histopathological diagnosis and prognostic significance. Oncol Rev. 2017;11(1):317.","journal-title":"Oncol Rev"},{"issue":"2","key":"3947_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.humpath.2013.10.011","volume":"45","author":"AL Moreira","year":"2014","unstructured":"Moreira AL, Joubert P, Downey RJ, Rekhtman N. Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma. Hum Pathol. 2014;45(2):213\u201320.","journal-title":"Hum Pathol"},{"issue":"5","key":"3947_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/modpathol.2013.188","volume":"27","author":"K Kadota","year":"2014","unstructured":"Kadota K, Yeh YC, Sima CS, Rusch VW, Moreira AL, Adusumilli PS, et al. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol. 2014;27(5):690\u2013700.","journal-title":"Mod Pathol"},{"issue":"2","key":"3947_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.prp.2018.12.014","volume":"215","author":"Y Qu","year":"2019","unstructured":"Qu Y, Lin H, Zhang C, Li K, Zhang H. Cribriform pattern in lung invasive adenocarcinoma correlates with poor prognosis in a Chinese cohort. Pathol Res Pract. 2019;215(2):347\u201353.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"3947_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"2","key":"3947_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.lungcan.2014.02.007","volume":"84","author":"Y Pan","year":"2014","unstructured":"Pan Y, Zhang Y, Li Y, Hu H, Wang L, Li H, et al. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features. Lung Cancer. 2014;84(2):121\u20136.","journal-title":"Lung Cancer"},{"issue":"4","key":"3947_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/modpathol.2014.107","volume":"28","author":"SE Lee","year":"2015","unstructured":"Lee SE, Lee B, Hong M, Song JY, Jung K, Lira ME, et al. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma. Mod Pathol. 2015;28(4):468\u201379.","journal-title":"Mod Pathol"},{"issue":"10","key":"3947_CR21","doi-asserted-by":"publisher","first-page":"e76999","DOI":"10.1371\/journal.pone.0076999","volume":"8","author":"H Kim","year":"2013","unstructured":"Kim H, Jang SJ, Chung DH, Yoo SB, Sun P, Jin Y, et al. A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype. PLoS ONE. 2013;8(10):e76999.","journal-title":"PLoS ONE"},{"issue":"1","key":"3947_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ajcp\/aqy032","volume":"150","author":"M Kuang","year":"2018","unstructured":"Kuang M, Shen X, Yuan C, Hu H, Zhang Y, Pan Y, et al. Clinical significance of complex glandular patterns in lung adenocarcinoma: clinicopathologic and molecular study in a large series of cases. Am J Clin Pathol. 2018;150(1):65\u201373.","journal-title":"Am J Clin Pathol"},{"issue":"21","key":"3947_CR23","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","volume":"26","author":"JP Pignon","year":"2008","unstructured":"Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J Clin Oncol. 2008;26(21):3552\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3947_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jtcvs.2017.09.143","volume":"155","author":"F Qian","year":"2018","unstructured":"Qian F, Yang W, Wang R, Xu J, Wang S, Zhang Y, et al. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma. J Thorac Cardiovasc Surg. 2018;155(3):1227\u2013e352.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"3947_CR25","doi-asserted-by":"publisher","first-page":"110104","DOI":"10.1016\/j.ejso.2025.110104","volume":"51","author":"H Du","year":"2025","unstructured":"Du H, Li X, Wang Y, Wang Q, Tao Y, Cui X, et al. Benefit of adjuvant chemotherapy for resected stage I lung cancer with spread through air spaces: a systematic review and meta-analysis. Eur J Surg Oncol. 2025;51(8):110104.","journal-title":"Eur J Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03947-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03947-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03947-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:56:32Z","timestamp":1757246192000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03947-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3947"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03947-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was performed in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Qilu Hospital of Shandong University. A waiver of informed consent was obtained due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"284"}}